Herbalife Ltd. (HLF) Next Earnings Date & Expected ±8% Move

$13.05 +0.93% NYSE • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $13.05

Herbalife Ltd. (HLF) carries a Roarable Rating of C (Hold) with 64/100 RQD Confidence. The composite score sits in the neutral Hold band (59–69), meaning current holders don’t need to panic-sell while prospective buyers can wait for a move into the 70+ Buy zone.

ROARABLE C • HOLD / WATCH Cap $1.36B
📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card
⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on HLF Below — or Connect Your Own ChatGPT / Claude
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is HLF stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼

As of 2026-11-02, Herbalife Ltd. (NYSE: HLF) is rated C (Hold / HOLD) by Roarable's 5-pillar RQD engine with a composite confidence score of 64/100 at a spot price of $13.05 (+0.93% 1D, market cap $1.36B). Pillar breakdown: Fundamental Cash Engine 18/20, Institutional 13F & Options Flow 8/20, Executive Insider Alignment 12/20, FRED Macro Regime Fit 9/20, and SEC Balance-Sheet Forensics 17/20. Across 1016 tracked Health Care issuers, HLF ranks #140 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does HLF compare to NUS and ZSTK in the Health Care sector?
▼

Within the Health Care sector (Other Pharmaceuticals), HLF carries a Roarable C (64/100 RQD), trailing P/E of 5.9x, gross margin of 77.9%, and ROIC of 34.4%. By comparison, NUS (Nu Skin Enterprises Inc.) holds a D+ grade (53/100 RQD, P/E N/A, ROIC 6.7%, cap $228.3M) and ZSTK (ZeroStack Corp.) posts a E grade (25/100 RQD, P/E N/A, ROIC -35.0%, cap $63.9M). Among the 5-stock peer group, HLF leads on earnings multiple (5.9x) while HLF leads on capital efficiency (34.4% ROIC).

✓ Pre-computed one-to-many AI Quant brief
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for HLF?
▼

Per HLF's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001180262), Herbalife Ltd. generated $5.04B in revenue (+0.9% YoY), $228.3M in net income, and $252.9M in free cash flow against $2.79B in total assets and $1.97B in total debt. Key quantitative strengths: Strong cash generator (78% profit margin)—profits are backed by real money, not accounting tricks.. Primary risk factors monitored: Sensitive to high interest rates and tighter Federal Reserve market liquidity.. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief
🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
🛡️ Portfolio Crash X-Ray
EXT / AFTER-HRS: $13.05 (-0.02%)🧬 Cannibal Buyback (-2.64% YoY Shares)⚙️ Cash Engine: 18/20 (A) • 5% FCF Margin
Verify 90D Bucket Audit →
📊 Historical Track Record: Scores of 64/100 (C) historically posted market-perform odds over rolling 90-day windows (+1.1% avg 90D alpha vs SPY • 55.2% hit rate — wait for RQD ≥ 70 breakout).
Audit Bucket Track Record →
RQD QUANT TACHOMETERHOLD / WATCH • C
025507510064
JEV AI Jury Split (Battleground)
Cash
SEC
Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw B · Rk D+
Cash (18)Whales (8)SEC (12)Macro (9)CEO (17)
Each axis scored 0–20
12M PRICE TARGET CONE+2.7% Base Target
$21 Bull$13 Base$10 Bear
📬 FREE HLF RATING-CHANGE & BRIEFING ALERTSManage / Unsubscribe
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for HLF)Realized 20D OHLCV Swing Band: ±8%
Deterministic 5-Pillar Attribution (64/100 Composite)
🔍 WHY HLF SCORES 64/100 (C) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: Cash Engine Quality+18/20 pts (28% of score)

SEC XBRL FY 2025 (10-K): 5% FCF Margin ($252.9M FCF) & 77.9% Gross Margin

▲ #2 Bullish Driver: Insider Conviction & Share Dilution+17/20 pts (27% of score)

SEC Form 4 / 13F Thermometer: 85% Net Buy • Cannibal Buyback (-2.64% YoY Shares)

▼ #1 Drag / Risk Factor: Whale & Options Positioning8/20 pts (-12 pt drag)

Put hedging (50% put share) caps near-term gamma upside (-12 pts vs max)

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)
72
Grade B$13.61+2% Next Q
Q2 (-2Q)
69
Grade B-$13.88-4.3% Next Q
Q3 (-1Q)
67
Grade B-$13.28-1.7% Next Q
Current
64
Grade C$13.05+1.1% Hist 90D α
Trajectory: B (72) → C (64)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER

⚔️ Adversarial Opposing Case: Why the HLF Bull Thesis Could Fail

Gideon Ashmere Forensic Desk →

Even with a 64/100 (C) score, HLF faces multiple-compression risk if 5.9x trailing P/E re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.

⚠️ Forensic Kill-Switch #1

Sensitive to high interest rates and tighter Federal Reserve market liquidity.

⚠️ Forensic Kill-Switch #2

Recent SEC filings added new risk-factor disclosures that warrant keeping an eye on margins.

⚠️ Forensic Kill-Switch #3

Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($12.72) or 200D SMA ($13.99) invalidates the momentum regime and cuts Target Base ($13.40) toward Bear Floor ($10.45).

🎲 LIVE PREDICTION MARKET ODDS TIED TO $HLF• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “HLF Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”
NEXT EST. WINDOW: Dec 30, 2026 (~57 DAYS)

Historical OHLCV Volatility ±8% Swing Band

±$1.04 Expected Swing
$12.01 (-8%)Spot $13.05$14.09 (+8%)
MODEL EARNINGS SETUP GAUGE

HLF Quantitative Pre-Earnings Setup: 64/100

Trailing EPS: $2.18 • YoY Revenue Growth: 0.9%

Model Bullish Setup (64/100)Model Risk Weight (36/100)
Derived deterministically from RQD cash-flow quality, SEC accrual safety, and institutional flow (not a community poll).
LOG YOUR PERSONAL PRE-EARNINGS STANCE (SAVED LOCALLY IN BROWSER):

Recent SEC Reported Revenue, Net Profit & Diluted EPS Cadence

PeriodFiledRevenueNet ProfitFree Cash FlowGross Margin
FY 20252025-12-31$5.04B$228.3M$252.9M77.9%
FY 20242024-12-31$4.99B$254.3M$163.4M77.9%
FY 20232023-12-31$5.06B$142.2M$357.5M77.9%
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher + Options & Swing Structure Desk

Whale Flow & Momentum Playbook: Evaluating HLF & AI Leaders Without Chasing Tops

  • ✓Institutional whale strikes & implied earnings move audit on HLF
  • ✓How disciplined traders manage risk using pre-published trigger & invalidation levels
  • ✓Includes nightly RQD rating-change & forensic signal email alerts on tracked leaders
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
HLF // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -17.51%📐 HORIZONTAL RANGE
2026-11-02O $13.38H $13.38L $12.93C $13.05VOL 1.65M
RES: $15.29SUP: $9.85SMA50: $12.72SMA200: $13.99
$17.27$15.41$13.55$11.69$9.83RES $15.29SUP $9.85$13.052026-05-042026-06-172026-08-042026-09-172026-11-02
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

HLF Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)
-11.1%/yr Implied 5Y Growth

vs. +0.9% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on HLF today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for HLF. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for HLF today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (HLF)

Health Care Rank #140 of 1016 ⚔️ NUS vs HLF Full Matrix →

1. Head-to-Head Health Care Peer Comparison (HLF vs. NUS, ZSTK, ESYN, CAH)

Industry: Other Pharmaceuticals (10 Tracked Issuers)

Across 1016 tracked Health Care securities in the Roarable RQD universe, Herbalife Ltd. (HLF) ranks #140 by composite RQD confidence (64/100, grade C) and #320 by equity capitalization ($1.36B). Within this direct 5-issuer industry benchmark cohort, HLF leads on earnings valuation at 5.9x trailing P/E, while HLF leads on capital efficiency and profitability with 34.4% ROIC and 77.9% gross margin. CAH currently holds the highest overall quantitative score in the immediate peer group at 73/100 (B) compared with HLF at 64/100 (C).

Ticker / Company Roarable Grade RQD Score Trailing P/E Gross Margin ROIC 1D Change Market Cap Head-to-Head
HLF ACTIVE
Herbalife Ltd.
C 64/100 5.9x 77.9% 34.4% +0.93% $1.36B Benchmark Subject
NUS
Nu Skin Enterprises Inc.
D+ 53/100 — 69.4% 6.7% -0.85% $228.3M /nus-vs-hlf →
ZSTK
ZeroStack Corp.
E 25/100 — 4.6% -35.0% -5.12% $63.9M /zstk-vs-hlf →
ESYN
EnerSyn Global Inc.
D- 40/100 — 53.0% -35.0% -4.37% $54.4M /esyn-vs-hlf →
CAH
Cardinal Health Inc.
B 73/100 37.2x 3.7% 29.7% -0.24% $58.14B /cah-vs-hlf →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001180262

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Herbalife Ltd. (HLF) reported GAAP revenue of $5.04B (+0.9% vs. FY2024 revenue of $4.99B , and -0.5% cumulative change since FY2023) , GAAP net income of $228.3M, operating cash flow of $333.3M, and free cash flow of $252.9M (+54.8% YoY). On the balance sheet, HLF closed FY2025 with $2.79B in total assets against $1.97B in total debt (Altman Z-Score: 2.39, Piotroski F-Score: 6/9).

Fiscal Period Filing Date Revenue Net Income Operating Cash Flow Free Cash Flow Total Assets Total Debt
FY2025 (FY) 2025-12-31 $5.04B $228.3M $333.3M $252.9M $2.79B $1.97B
FY2024 (FY) 2024-12-31 $4.99B $254.3M $285.4M $163.4M $2.73B $1.98B
FY2023 (FY) 2023-12-31 $5.06B $142.2M $357.5M $357.5M — —

3. HLF Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is HLF stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-02, Herbalife Ltd. (NYSE: HLF) is rated C (Hold / HOLD) by Roarable's 5-pillar RQD engine with a composite confidence score of 64/100 at a spot price of $13.05 (+0.93% 1D, market cap $1.36B). Pillar breakdown: Fundamental Cash Engine 18/20, Institutional 13F & Options Flow 8/20, Executive Insider Alignment 12/20, FRED Macro Regime Fit 9/20, and SEC Balance-Sheet Forensics 17/20. Across 1016 tracked Health Care issuers, HLF ranks #140 in composite RQD confidence.

How does HLF compare to NUS and ZSTK in the Health Care sector?

Within the Health Care sector (Other Pharmaceuticals), HLF carries a Roarable C (64/100 RQD), trailing P/E of 5.9x, gross margin of 77.9%, and ROIC of 34.4%. By comparison, NUS (Nu Skin Enterprises Inc.) holds a D+ grade (53/100 RQD, P/E N/A, ROIC 6.7%, cap $228.3M) and ZSTK (ZeroStack Corp.) posts a E grade (25/100 RQD, P/E N/A, ROIC -35.0%, cap $63.9M). Among the 5-stock peer group, HLF leads on earnings multiple (5.9x) while HLF leads on capital efficiency (34.4% ROIC).

What are the biggest fundamental strengths and SEC risk factors for HLF?

Per HLF's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001180262), Herbalife Ltd. generated $5.04B in revenue (+0.9% YoY), $228.3M in net income, and $252.9M in free cash flow against $2.79B in total assets and $1.97B in total debt. Key quantitative strengths: Strong cash generator (78% profit margin)—profits are backed by real money, not accounting tricks.. Primary risk factors monitored: Sensitive to high interest rates and tighter Federal Reserve market liquidity.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is HLF trading relative to its 50-day, 200-day, and 52-week technical levels?

HLF last traded at $13.05 (+0.93% on volume of 1,520,210 shares), positioning the stock +2.59% above its 50-day simple moving average ($12.72) and -6.72% below its 200-day simple moving average ($13.99). Across its 52-week range of $7.56 to $20.40, HLF sits at the 42.8% percentile with a 14-day RSI of 45.7 (NEUTRAL RANGE) and an implied next-earnings move of ±8.0% ($12.01 to $14.09).

HLF Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

When is HLF's next earnings date?

Based on SEC filing cadence, Herbalife Ltd. (HLF)'s next quarterly reporting window is estimated around Dec 30, 2026.

How much is HLF stock expected to move on earnings?

Volatility modeling currently projects a ±8% event move for HLF, spanning a range between $12.01 and $14.09.

ROARABLE RATING BRIEF • RQD 64/100 (C) ✓ STAGE-C NUMBER FIREWALL VERIFIED

HLF — Herbalife Ltd.: What the Facts Mean to a Prospective Investor

Engine: anthropic/claude-haiku-5.5
As of: 2026-11-02T15:29:29Z

Roarable Rating Brief: What This Means to a Prospective Investor

Per the Roarable RQD rating, HLF scores 64 out of 100, earning a letter grade of C and the verdict "Roarable Hold — Fair / Balanced Risk-Reward." The five pillars are: Fundamental Cash Engine at 18 of 20 (ROIC 34.4%; FCF yield 18.66%), the strongest contributor and the main source of the score; Whale 13F Flow at 8 of 20 (institutional accumulation and options positioning), a weak contributor; Insider Conviction at 17 of 20 (SEC Form 4 and Congressional PTR cluster flow), a strong contributor; Macro Regime Fit at 9 of 20 (beta 1.0; sector sensitivity), a middling contributor; and Forensic Balance Sheet at 12 of 20 (Altman Z 2.39; Piotroski F 6/9; Debt/Equity 0.5), a moderate contributor.

For a prospective investor evaluating the stock today, the pillar mix suggests the cash-generation case is the principal argument in favor, supported by insider-flow signals. The lower whale-flow and macro-fit scores indicate less institutional confirmation and a beta of 1.0 that tracks the broader market and sector. Valuation tradeoffs are visible in the market data: a trailing P/E of 5.9 and EV/EBITDA of 5.4 sit alongside an FCF yield of 18.66%, while the stock trades near the lower portion of its 52-week range. The balance sheet is rated as moderate rather than weak, but the Altman and Piotroski readings and reported debt of $1971.7M warrant attention in weighing downside scenarios. This is an analytical summary, not personalized advice.

Snapshot

PriceMarket CapP/E (TTM)Forward P/EEV/EBITDAEPS (TTM)Dividend YieldBeta52-Wk RangeROIC %
12.93$1.36B5.95.55.42.180%1.0$7.56 - $20.434.4%

Business

Herbalife Ltd. (HLF) is a NYSE-listed issuer in the Health Care sector and Other Pharmaceuticals industry, per the Profile. Per the Market Data, the company reports a gross margin of 77.9%, an operating margin of 9.5%, and a net margin of 4.5%. Not available in source data for product lines, customer segments, or specific revenue-generation mechanics.

Financial Trend

PeriodRevenueOperating IncomeNet IncomeEPSFCFCashDebt
FY 2025$5037.5M$481.0M$228.3MN/A$252.9M$353.1M$1971.7M
FY 2024$4993.1M$385.9M$254.3MN/A$163.4M$415.3M$1976.6M
FY 2023$5062.4M$356.4M$142.2MN/A$357.5MN/AN/A

Per the SEC financials, revenue was broadly flat across the three reported periods, while operating income rose from $356.4M (FY 2023) to $481.0M (FY 2025). Net income moved from $142.2M to $254.3M and then to $228.3M. Per the Roarable RQD rating, ROIC is 34.4%, and the forensic inputs are an Altman Z-Score of 2.39, a Piotroski F-Score of 6/9, and a Debt/Equity ratio of 0.5. Cash declined from $415.3M to $353.1M over the two most recent periods, while debt was broadly stable at $1976.6M and $1971.7M.

Recent Catalysts & News Wire Analysis

Per the recent news data, the feed contains six items dated within roughly the past 15 hours, tagged by impact label:

  • Market Wire (YELLOW): Yahoo! Finance Canada and Yahoo Finance coverage of general market action and fair-value commentary.
  • Catalyst (GREEN): GuruFocus reported a share move of 4.5% alongside a GF Score of 62; MarketBeat reported a 5% share move.
  • Risk Watch (RED): Benzinga listed HLF among "Top 3 Risk Off Stocks" for Q4.
  • Catalyst (GREEN): Simply Wall St coverage addressed investor reaction to slowing sales growth.

Per the Butterfly Supply-Chain Graph, no proprietary signals or butterfly links are recorded. The headlines are summary-level and do not include underlying figures beyond those noted.

Open Questions

  • What drives the reported revenue plateau across FY 2023–FY 2025, and what is the company's stated growth trajectory?
  • What explains the decline in cash from $415.3M to $353.1M despite positive reported FCF in FY 2025?
  • What are the terms, maturities, and interest costs on the $1971.7M of reported debt?
  • What is the underlying basis for the 4.5% and 5% share moves referenced in the news wire, and do they reflect company-specific events?
  • Why is EPS reported as N/A for every period despite positive net income?

HLF Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for Herbalife Ltd. (HLF) • Click "Debate This Headline" to argue it in the Roar Pit below

💬 Jump to HLF Debate Forum (3) ↓
🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE 3 Active Posts & Replies

HLF Bull vs. Bear Conversation Board — What's Your Call at $13.05?

🐂 50% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON HLF 🐻 50% BEARISH CONVICTION
1. Pick Your Side on HLF:
💡 Tip: Back up your call with a price target or RQD metric to get upvoted to the top.
RO RoarDesk_Moderator Roarable Research Desk ⚖️ DEBATE HOST 🎯 Target: $13.96 (+8.0%)
📌 Pinned Debate

🔥 Official Bull vs. Bear Debate: Is HLF (C • RQD 64/100) a Buy at $12.93?

Welcome to the HLF (Herbalife Ltd.) Roar Pit. Current RQD Composite is 64/100 (Roarable Hold — Fair / Balanced Risk-Reward) in Other Pharmaceuticals. Bulls point to capital efficiency (34.4% ROIC), while bears focus on macro rate sensitivity and margin execution. Pick your side (🐂 Bull or 🐻 Bear) and drop your price target below.

FO ForensicBear Forensic Accounting Watch 🐻 BEARISH 🎯 Target: $10.21 (-21.0%)
Spot @ $12.93

Pump the brakes on HLF — check the valuation vs. margin headwinds

Everyone in here is repeating the bull case on HLF, but look at what you are paying: 5.9x trailing P/E with 77.9% gross margins. Unless Herbalife Ltd. expands free cash flow yield next quarter, I would rather wait for a pullback closer to the 200-day moving average before touching this.

DE DeltaGamma_99 Verified K Arena Trader 🐂 BULLISH 🎯 Target: $16.03 (+24.0%)
Spot @ $12.93

HLF cash flow & RQD setup is being underpriced by the Street here

Looking at the 5-pillar RQD breakdown on HLF, the market is fixating on short-term headline noise in Other Pharmaceuticals and ignoring the balance sheet and cash flow trajectory. At $12.93 (52-wk range $7.56 - $20.40), any beat on forward guidance forces shorts and underweight funds to chase.

LIVE TAPE SPY $755.72 -0.38% QQQ $690.49 -1.44% DIA $517.13 -0.37% IWM $279.33 +0.96% NVDA $204.64 -4.22% AAPL $344.63 -1.23% MSFT $521.91 -1.55% TSLA $399.81 -0.86% PLTR $184.11 -6.27% SOFI $16.76 -4.83% IBIT $43.36 -0.94% GLD $355.78 -1.34%